NanoVir Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

NanoVir General Information

Description

Operator of a drug research company intended to discover the treatments for human papillomavirus or HPV using novel chemical and biological approaches to develop DNA-targeted therapies. The company's services mainly focus on developing DNA-targeted therapies for the treatment of human papillomavirus, enabling clients to get access to a series of compounds that dramatically reduce the viral DNA load of cells harboring the virus.

Contact Information

Website
www.nanovir.net
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 4717 Campus Drive
  • Suite 1300
  • Kalamazoo, MI 49008
  • United States
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 4717 Campus Drive
  • Suite 1300
  • Kalamazoo, MI 49008
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoVir Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 10-Jan-2022 Completed Out of Business
4. Grant 31-Jul-2013 Completed Generating Revenue
3. Grant 11-May-2010 Completed Startup
2. Grant 01-Jan-2004 $998K Completed Startup
1. Accelerator/Incubator Completed Startup
To view NanoVir’s complete valuation and funding history, request access »

NanoVir Patents

NanoVir Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016022664-A1 Antiviral compounds and methods for treating infections caused by double-stranded dna viruses Inactive 05-Aug-2014
US-20150239943-A1 Compounds for treating papilloma virus infection Active 25-Jan-2012
US-9290551-B2 Compounds for treating papilloma virus infection Inactive 25-Jan-2012
US-20150329596-A1 Antiviral compounds and methods for treating infections caused by double-stranded dna viruses Active 10-Oct-2011
US-9982020-B2 Antiviral compounds and methods for treating infections caused by double-stranded dna viruses Inactive 10-Oct-2011 C07K14/00
To view NanoVir’s complete patent history, request access »

NanoVir FAQs

  • When was NanoVir founded?

    NanoVir was founded in 2003.

  • Where is NanoVir headquartered?

    NanoVir is headquartered in Kalamazoo, MI.

  • What industry is NanoVir in?

    NanoVir’s primary industry is Drug Discovery.

  • Is NanoVir a private or public company?

    NanoVir is a Private company.

  • What is NanoVir’s current revenue?

    The current revenue for NanoVir is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process